VERASTEM INC (VSTM) Fundamental Analysis & Valuation

NASDAQ:VSTM • US92337C2035

Current stock price

6.58 USD
+0.24 (+3.79%)
At close:
6.58 USD
0 (0%)
After Hours:

This VSTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VSTM Profitability Analysis

1.1 Basic Checks

  • VSTM had negative earnings in the past year.
  • In the past year VSTM has reported a negative cash flow from operations.
  • In the past 5 years VSTM always reported negative net income.
  • In the past 5 years VSTM always reported negative operating cash flow.
VSTM Yearly Net Income VS EBIT VS OCF VS FCFVSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M

1.2 Ratios

  • VSTM has a worse Return On Assets (-85.00%) than 71.18% of its industry peers.
  • Looking at the Return On Equity, with a value of -366.23%, VSTM is doing worse than 75.24% of the companies in the same industry.
Industry RankSector Rank
ROA -85%
ROE -366.23%
ROIC N/A
ROA(3y)-90.67%
ROA(5y)-83.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSTM Yearly ROA, ROE, ROICVSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

1.3 Margins

  • The Gross Margin of VSTM (82.86%) is better than 85.88% of its industry peers.
  • VSTM's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for VSTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.08%
GM growth 5Y5.71%
VSTM Yearly Profit, Operating, Gross MarginsVSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. VSTM Health Analysis

2.1 Basic Checks

  • VSTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VSTM has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for VSTM has been increased compared to 5 years ago.
  • The debt/assets ratio for VSTM has been reduced compared to a year ago.
VSTM Yearly Shares OutstandingVSTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VSTM Yearly Total Debt VS Total AssetsVSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -6.20, we must say that VSTM is in the distress zone and has some risk of bankruptcy.
  • VSTM has a Altman-Z score of -6.20. This is in the lower half of the industry: VSTM underperforms 67.31% of its industry peers.
  • A Debt/Equity ratio of 1.42 is on the high side and indicates that VSTM has dependencies on debt financing.
  • VSTM's Debt to Equity ratio of 1.42 is on the low side compared to the rest of the industry. VSTM is outperformed by 77.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z -6.2
ROIC/WACCN/A
WACC9.39%
VSTM Yearly LT Debt VS Equity VS FCFVSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

2.3 Liquidity

  • A Current Ratio of 3.09 indicates that VSTM has no problem at all paying its short term obligations.
  • VSTM has a worse Current ratio (3.09) than 61.90% of its industry peers.
  • VSTM has a Quick Ratio of 3.07. This indicates that VSTM is financially healthy and has no problem in meeting its short term obligations.
  • VSTM's Quick ratio of 3.07 is on the low side compared to the rest of the industry. VSTM is outperformed by 60.54% of its industry peers.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 3.07
VSTM Yearly Current Assets VS Current LiabilitesVSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. VSTM Growth Analysis

3.1 Past

  • VSTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.43%, which is quite good.
  • VSTM shows a strong growth in Revenue. In the last year, the Revenue has grown by 209.14%.
  • The Revenue for VSTM have been decreasing by -18.97% on average. This is quite bad
EPS 1Y (TTM)13.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.41%
Revenue 1Y (TTM)209.14%
Revenue growth 3Y128.24%
Revenue growth 5Y-18.97%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 21.92% on average over the next years. This is a very strong growth
  • VSTM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 81.07% yearly.
EPS Next Y44.79%
EPS Next 2Y32.43%
EPS Next 3Y22.57%
EPS Next 5Y21.92%
Revenue Next Year280.05%
Revenue Next 2Y155.85%
Revenue Next 3Y112.31%
Revenue Next 5Y81.07%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VSTM Yearly Revenue VS EstimatesVSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
VSTM Yearly EPS VS EstimatesVSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. VSTM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VSTM. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VSTM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSTM Price Earnings VS Forward Price EarningsVSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSTM Per share dataVSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • VSTM's earnings are expected to grow with 22.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.43%
EPS Next 3Y22.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VSTM Dividend Analysis

5.1 Amount

  • No dividends for VSTM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VSTM Fundamentals: All Metrics, Ratios and Statistics

VERASTEM INC

NASDAQ:VSTM (4/17/2026, 8:00:02 PM)

After market: 6.58 0 (0%)

6.58

+0.24 (+3.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)05-11
Inst Owners84.02%
Inst Owner Change-0.23%
Ins Owners0.58%
Ins Owner Change1.29%
Market Cap577.99M
Revenue(TTM)30.91M
Net Income(TTM)-209.47M
Analysts85.33
Price Target17.05 (159.12%)
Short Float %19.48%
Short Ratio8.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-49.21%
Min EPS beat(2)-108.2%
Max EPS beat(2)9.78%
EPS beat(4)2
Avg EPS beat(4)-14.72%
Min EPS beat(4)-108.2%
Max EPS beat(4)48.42%
EPS beat(8)4
Avg EPS beat(8)-6.99%
EPS beat(12)6
Avg EPS beat(12)-10.57%
EPS beat(16)8
Avg EPS beat(16)-5.87%
Revenue beat(2)2
Avg Revenue beat(2)49.3%
Min Revenue beat(2)3.86%
Max Revenue beat(2)94.73%
Revenue beat(4)3
Avg Revenue beat(4)21.35%
Min Revenue beat(4)-100%
Max Revenue beat(4)94.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.54%
PT rev (3m)3.65%
EPS NQ rev (1m)-1.5%
EPS NQ rev (3m)17.66%
EPS NY rev (1m)4.93%
EPS NY rev (3m)12.24%
Revenue NQ rev (1m)0.2%
Revenue NQ rev (3m)29.6%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)9.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.7
P/FCF N/A
P/OCF N/A
P/B 10.11
P/tB 14.18
EV/EBITDA N/A
EPS(TTM)-3.03
EYN/A
EPS(NY)-1.67
Fwd EYN/A
FCF(TTM)-1.68
FCFYN/A
OCF(TTM)-1.57
OCFYN/A
SpS0.35
BVpS0.65
TBVpS0.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -85%
ROE -366.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.86%
FCFM N/A
ROA(3y)-90.67%
ROA(5y)-83.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.08%
GM growth 5Y5.71%
F-Score6
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1321.98%
Cap/Sales 31.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.09
Quick Ratio 3.07
Altman-Z -6.2
F-Score6
WACC9.39%
ROIC/WACCN/A
Cap/Depr(3y)476.56%
Cap/Depr(5y)304.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.41%
EPS Next Y44.79%
EPS Next 2Y32.43%
EPS Next 3Y22.57%
EPS Next 5Y21.92%
Revenue 1Y (TTM)209.14%
Revenue growth 3Y128.24%
Revenue growth 5Y-18.97%
Sales Q2Q%N/A
Revenue Next Year280.05%
Revenue Next 2Y155.85%
Revenue Next 3Y112.31%
Revenue Next 5Y81.07%
EBIT growth 1Y-47.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y45.93%
EBIT Next 5Y14.17%
FCF growth 1Y-40.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.25%
OCF growth 3YN/A
OCF growth 5YN/A

VERASTEM INC / VSTM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VERASTEM INC?

ChartMill assigns a fundamental rating of 2 / 10 to VSTM.


Can you provide the valuation status for VERASTEM INC?

ChartMill assigns a valuation rating of 1 / 10 to VERASTEM INC (VSTM). This can be considered as Overvalued.


How profitable is VERASTEM INC (VSTM) stock?

VERASTEM INC (VSTM) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for VSTM stock?

The Earnings per Share (EPS) of VERASTEM INC (VSTM) is expected to grow by 44.79% in the next year.